https://www.massgeneral.org/doctors/18613/amir-fathi
Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD
Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely administer and manage them.